Regulation of sarcolemmal Na+/H+ exchanger activity by angiotensin II in adult rat ventricular myocytes opposing actions via AT1 versus AT2 receptors

Circulation Research

Volumn 85, Issue 10, 1999, Pages 919-930

  Gunasegaram, Suba ^b   Haworth, Robert S ^b   Hearse, David J ^b   Avkiran, Metin ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b NONE

Author keywords

Angiotensin; Extracellular signal regulated kinase; Myocyte; Na+ H+ exchanger; Signal transduction

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; LOSARTAN; NICOTINOYLTYROSYL(N BENZYLOXYCARBONYLARGINYL)LYSYLHISTIDYLPROLYLISOLEUCINE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME PHOSPHORYLATION; HEART MUSCLE CELL; HEART VENTRICLE WALL; HORMONE RECEPTOR INTERACTION; IMMUNOBLOTTING; MALE; NONHUMAN; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; RAT; SARCOLEMMA;

EID: 0032695140     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.85.10.919     Document Type: Article

References (56)

1. Fliegel L, Dyck JRB. Molecular biology of the cardiac sodium/hydrogen exchanger. Cardiovasc Res. 1995;29:155-159.
2. + exchange in cardiac physiology and pathophysiology: mediation of myocardial reperfusion injury by the pH paradox. Cardiovasc Res. 1993;27:915-924.
3. Pucéat M, Vassort G. Neurohumoral modulation of intracellular pH in the heart. Cardiovasc Res. 1995;29:178-183.
4. 1A-adrenoceptor subtype. Circ Res. 1998;81:1078-1085.
5. + exchanger. Circ Res. 1991;68:269-279.
6. + exchanger: evidence for a receptor-mediated mechanism involving protein kinase C. Circ Res. 1996;79:705-715.
7. + exchanger isoforms. Am J Physiol. 1995;268:C283-C296.
8. + exchange is impaired in cardiac hypertrophy. J Clin Invest. 1997;99:125-135.
9. Matsui H, Barry WH, Livsey CV, Spitzer KW. Angiotensin II stimulates sodium-hydrogen exchange in adult rabbit ventricular myocytes. Cardiovasc Res. 1995;29:215-221.
10. Suzuki J, Matsubara H, Urakami M, Inada M. Rat angiotensin II (type IA) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res. 1993;73:439-447.
11. Baker KM, Campanile CP, Trachte GJ, Peach MJ. Identification and characterization of the rabbit angiotensin II myocardial receptor. Circ Res. 1984;54:286-293.
12. 2 angiotensin receptor gene expression in human heart failure. Circulation. 1997;95:1201-1206.
13. 1-receptor subtype in failing human ventricular myocardium. Circulation. 1997;95:1193-1200.
14. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest. 1995;95:651-657.
15. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A. 1996;93:156-160.
16. Booz GW, Baker KM. Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension. 1996; 28:635-640.
17. Huang X-C, Richards EM, Sumner C. Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angiotensin II type 2 receptors. J Biol Chem. 1996;271:15635-15641.
18. 1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A. 1995;92: 10663-10667.
19. + exchanger (NHE1 isoform) in response to growth factors. J Biol Chem. 1997;272:271-279.
20. + exchanger during postnatal development in the rat: changes in mRNA expression and sarcolemmal activity. J Mol Cell Cardiol. 1997;29: 321-332.
21. + exchanger activity does not contribute to protection by ischemic preconditioning in the isolated rat heart. Circulation. 1997; 96:3617-3625.
22. 2) receptor protein in rat kidney. Hypertension. 1997;30:1238-1246.
23. Wang Z-Q, Moore AF, Ozono R, Siragy HM, Carey RM. Immunolocalization of subtype 2 angiotensin II (AT2) receptor protein in rat heart. Hypertension. 1998;32:78-83.
24. Fareh J, Touyz RM, Schiffrin EL, Thibault G. Cardiac type-1 angiotensin II receptor status in deoxycorticosterone acetate-salt hypertension in rats. Hypertension. 1997;30:1253-1259.
25. Meggs LG, Coupet J, Huang H, Cheng W, Li P, Capasso JM, Homcy CJ, Anversa P. Regulation of angiotensin II receptors on ventricular myocytes after myocardial infarction in rats. Circ Res. 1993;72:1149-1162.
26. Lopez JJ, Lorell BH, Ingelfinger JR, Weinberg EO, Schunkert H, Diamant D, Tang S. Distribution and function of cardiac angiotensin AT1- and AT2- receptor subtypes in hypertrophied rat hearts. Am J Physiol. 1994;267:H844-H852.
27. Dudley DT, Pang L, Decker SJ, Bridges AJ, Saltiel AR. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A. 1995;92:7686-7689.
28. Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem. 1995;270:27489-27494.
29. Zou Y, Komuro I, Yamazaki T, Aikawa R, Kudoh S, Shiojima I, Hiroi Y, Mizuno T, Yazaki Y. Protein kinase C, but not tyrosine kinases or Ras, plays a critical role in angiotensin II-induced activation of REaf-1 kinase and extracellular signal-regulated protein kinases in cardiac myocytes. J Biol Chem. 1996;271:33592-33597.
30. Eguchi S, Numaguchi K, Iwasaki H, Matsumoto T, Yamakawa T, Utsunomiya H, Motley ED, Kawakatsu H, Owada KM, Hirata Y, Marumo F, Inagami T. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J Biol Chem. 1998;273:8890-8896.
31. 2+/calmodulin-dependent transactivation of epidermal growth factor receptor. Circ Res. 1998;82:1338-1348.
32. ++-dependent signaling. Circ Res. 1995;76:1-15.
33. + antiporter in vascular smooth muscle. Hypertension. 1996;27:72-78.
34. 2+ modulation. Circ Res. 1996;78:302-311.
35. Kijima K, Matsubara H, Murasawa S, Maruyama K, Mori Y, Ohkubo N, Komuro I, Yazaki Y, Iwasaka T, Inada M. Mechanical stretch induces enhanced expression of angiotensin II receptor subtypes in neonatal rat cardiac myocytes. Circ Res. 1996;79:887-897.
36. Bartunek J, Weinberg EO, Tajima M, Rohrbach S, Lorell BH. Angiotensin II type 2 receptor blockade amplifies the early signals of cardiac growth response to angiotensin II in hypertrophied hearts. Circulation. 1999;99:22-25.
37. 1 receptor-mediated pressor and chronotropic effects. J Biol Chem. 1998;101: 527-535.
38. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BLM, Inagama T. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature. 1995;377:748-750.
39. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor gene in mice. Nature. 1995;377:744-747.
40. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res. 1998;83:1182-1191.
41. + exchangers of mammalian cells. J Biol Chem. 1997;272:22373-22376.
42. + exchangers. Physiol Rev. 1997;77:51-74.
43. Liao D-F, Duff JL, Daum G, Pelech SL, Berk BC. Angiotensin II stimulates MAP kinase kinase activity in vascular smooth muscle cells: role of Raf. Circ Res. 1996;79:1007-1014.
44. FAK) in cultured rat cardiac myocytes. Biochem Biophys Res Commun. 1999;259:8-14.
45. Tsai W, Morielli AD, Peralta EG. The m1 muscarinic acetylcholine receptor transactivates the EGF receptor to modulate ion channel activity. EMBO J. 1997;16:4597-4605.
46. + exchanger through mitogen-activated protein kinase. Biochemistry. 1997; 36:9151-9158.
47. + exchanger kinase. Circ Res. 1997;81:268-273.
48. + exchange and ERK1/2. Circ Res. 1998;83:824-831.
49. + exchanger activity. Am J Physiol. In press.
50. Lin X, Barber DL. A calcineurin homologous protein inhibits GTPase-stimulated Na-H exchange. Proc Natl Acad Sci U S A. 1996;93: 12631-12636.
51. + antiporter (NHE-1) gene expression during growth, hypertrophy and proliferation of the rabbit cardiovascular system. J Mol Cell Cardiol. 1995;27:729-742.
52. Yamazaki T, Komuro I, Kudoh S, Zou Y, Nagai R, Aikawa R, Uozumi H, Yazaki Y. Role of ion channels and exchangers in mechanical stretch-induced cardiomyocyte hypertrophy. Circ Res. 1998;82:430-437.
53. i and creatine phosphate on α-adrenoceptor-mediated cardiac hypertrophy. J Mol Cell Cardiol 1998;30:763-771.
54. + exchange inhibitors in myocardial ischemia. Am J Cardiol. 1999;83:10G-18G.
55. Christen Y, Waeber B, Nussberger J, Porchet M, Borland RM, Lee RJ, Maggon K, Shum L, Timmermans P, Brunner HR. Oral administration of DUP-753, a specific angiotensin II receptor antagonist, to normal male volunteers: Inhibition of pressor response to exogenous angiotensin I and angiotensin II. Circulation. 1991;83:1333-1342.
56. Pitt R, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE). Lancet. 1997;349:747-752.